Utilizing the power of Cerenkov light with nanotechnology

Abstract

The characteristic blue glow of Cerenkov luminescence (CL) arises from the interaction between a charged particle travelling faster than the phase velocity of light and a dielectric medium, such as water or tissue. As CL emanates from a variety of sources, such as cosmic events, particle accelerators, nuclear reactors and clinical radionuclides, it has been used in applications such as particle detection, dosimetry, and medical imaging and therapy. The combination of CL and nanoparticles for biomedicine has improved diagnosis and therapy, especially in oncological research. Although radioactive decay itself cannot be easily modulated, the associated CL can be through the use of nanoparticles, thus offering new applications in biomedical research. Advances in nanoparticles, metamaterials and photonic crystals have also yielded new behaviours of CL. Here, we review the physics behind Cerenkov luminescence and associated applications in biomedicine. We also show that by combining advances in nanotechnology and materials science with CL, new avenues for basic and applied sciences have opened.

Nanoparticles to mediate X‐ray‐induced photodynamic therapy and Cherenkov radiation photodynamic therapy

“…(e) Co‐localization in vivo therapy results. (Reprinted with permission from Shaffer et al (), Kamkaew et al () and Kotagiri et al (). Copyright 2017, 2016 and 2018 American Chemical Society and Nature Publishing Group)…”

A novel in vivo Cerenkov luminescence image‐guided surgery on primary and metastatic colorectal cancer

“…By combining the advantages of both nuclear imaging and optical imaging, CLI owns the merits of high sensitivity, great imaging resolution and promising potential for clinical translation . So far, the outstanding performance of CLI has been demonstrated in the areas of tumor diagnosis, photodynamic therapy, treatment evaluation, and so on .…”

Multimodality Imaging Agents with PET as the Fundamental Pillar

“…Reproducedf rom Ref [39]. b) Schematic of the hybrid (PET/optical) imaging nanoprobes, Cdots, showing the core containing Cy5dye and surface-attached PEG chains that bear cRGDY peptide ligands (binding to human a v b 3 integrin-expressing tumors) and 124 Ir adiolabels.…”